Email updates

Keep up to date with the latest news and content from BMC Complementary and Alternative Medicine and BioMed Central.

This article is part of the supplement: Scientific Abstracts Presented at the International Research Congress on Integrative Medicine and Health 2012

Open Access Poster presentation

P02.155. Stress Management and Resilience Training (SMART) program to decrease stress and enhance resilience among breast cancer survivors: a randomized trial

A Sood*, C Loprinzi, V Sharma and K Prasad

  • * Corresponding author: A Sood

Author Affiliations

Mayo Clinic Rochester, Rochester, USA

For all author emails, please log on.

BMC Complementary and Alternative Medicine 2012, 12(Suppl 1):P211  doi:10.1186/1472-6882-12-S1-P211

The electronic version of this article is the complete one and can be found online at:

Published:12 June 2012

© 2012 Sood et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Patients with breast cancer experience considerable stress and anxiety related to their diagnosis, with resulting lower quality of life. The current study was designed to assess the effect of a Stress Management and Resiliency Training (SMART) program for increasing resiliency and decreasing stress and anxiety among a group of mentors who themselves previously were diagnosed with breast cancer (pink ribbon mentors).


Twenty-five pink ribbon mentors at Mayo Clinic Rochester were randomized in a single-blind wait-list controlled clinical trial to either the SMART intervention or a control group for twelve weeks. The intervention involved two 90 minute group training sessions followed by a brief individual session and four weekly telephone calls. After the initial group session, all participants in the intervention arm were provided with a DVD to practice paced breathing meditation. Primary outcome measures assessed at baseline and week 12 included the Connor Davidson Resilience Scale (CDRS), Perceived Stress Scale (PSS), Smith Anxiety Scale (SAS), and Linear Analog Self Assessment Scale (LASA).


Twenty patients completed the study. A statistically significant improvement in resilience, perceived stress, anxiety and overall quality of life at 12 weeks, compared to baseline, was observed in the study arm (CDRS: 73.6±10.1 vs. 81.3±9.1, p=0.010), (PSS: 22.1±5.9 vs. 12.8±6.6, p=0.003), (SAS: 49.4±18.2 vs. 33.3±11.7, p=0.002) and LASA (38.4±6.1 vs. 44.5±3.5, p=0.002). No significant difference in the any of these measures was noted in the control group.


This study demonstrates that a brief, predominantly group-based resilience training intervention is feasible in patients with previous breast cancer. Further, the intervention provided statistically significant and clinically meaningful improvement on resilience, stress, anxiety and overall quality of life. Future larger clinical trials with this intervention are warranted.